Company: INMB
Filing Date: 2025-03-07
Form Type: 424B5
Source: 0001213900-25-021719
Chunk: 40

Company: Inmune Bio, Inc.
Filing Date: 2025-03-07
Form: 424B5
Chunk 40
---
                                                       
 dividend rate(s), period(s) and/or payment date(s) or method(s) of calculation thereof applicable to the preferred stock; |

| ● | whether                                                                                                                                    
 dividends shall be cumulative or non-cumulative and, if cumulative, the date from which dividends on the preferred stock shall accumulate; |

| ● | the                                                             
 provisions for a sinking fund, if any, for the preferred stock; |

| ● | any                                   
 voting rights of the preferred stock; |

| ● | the                                                               
 provisions for redemption, if applicable, of the preferred stock; |

| ● | any                                                        
 listing of the preferred stock on any securities exchange; |

| ● | the                                                                                                                                     
 terms and conditions, if applicable, upon which the preferred stock will be convertible into our common stock, including the conversion 
 price or the manner of calculating the conversion price and conversion period;                                                          |

| ● | if                                                                                                  
 appropriate, a discussion of Federal income tax consequences applicable to the preferred stock; and |

| ● | any                                                                                            
 other specific terms, preferences, rights, limitations or restrictions of the preferred stock. |

The terms, if any, on which the preferred stock
may be convertible into or exchangeable for our common stock will also be stated in the preferred stock prospectus supplement. The terms
will include provisions as to whether conversion or exchange is mandatory, at the option of the holder or at our option, and may include
provisions pursuant to which the number of shares of our common stock to be received by the holders of preferred stock would be subject
to adjustment.

Transfer Agent and Registrar

The transfer agent for our common stock is VStock
Transfer, LLC. The transfer agent’s address is 18 Lafayette Place, Woodmere, New York 11598.

Listing

Our common stock is currently traded on The Nasdaq
Capital Market under the symbol “INMB”.

<div align='center'>8

DESCRIPTION OF WARRANTS</div>

We may issue warrants for the purchase of preferred
stock or common stock. Warrants may be issued independently or together with any preferred stock or common stock, and may be attached
to or separate from any offered securities. Each series of warrants will be issued under a separate warrant agreement to be entered into
between a warrant agent specified in the agreement and us. The warrant agent will act solely as our agent in connection with the warrants
of that series and will not assume any obligation or relationship of agency or trust for or with any holders or beneficial owners of warrants.
This summary of some